|Bid||17.00 x 800|
|Ask||20.33 x 800|
|Day's Range||19.10 - 19.49|
|52 Week Range||16.91 - 21.63|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||370.38|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
With its stock down 7.7% over the past three months, it is easy to disregard Amphastar Pharmaceuticals (NASDAQ:AMPH...
The impact of the coronavirus pandemic on the Zacks Medical-Generic Drugs industry is expected to recede in the second half of 2021. Moreover, stable pricing and improving demand in some countries in 2021 may bode well for RDY, BHC and AMPH.